Invention Grant
US09556130B2 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
有权
GPR139的4-氧代-3,4-二氢-1,2,3-苯并三嗪调节剂
- Patent Title: 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
- Patent Title (中): GPR139的4-氧代-3,4-二氢-1,2,3-苯并三嗪调节剂
-
Application No.: US14946194Application Date: 2015-11-19
-
Publication No.: US09556130B2Publication Date: 2017-01-31
- Inventor: Stephen Hitchcock , Betty Lam , Holger Monenschein , Holly Reichard
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agent Matthew J. Russo; David M. Stemerick
- Main IPC: C07D253/08
- IPC: C07D253/08 ; A61K31/53
Abstract:
The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula 1: which are agonists of GPR139, certain compounds encompassed by formula 1, pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.
Public/Granted literature
- US20160145218A1 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE MODULATORS OF GPR139 Public/Granted day:2016-05-26
Information query
